Takeda Pharmaceuticals, a Japanese drug manufacturer, is expanding its presence in India by looking into ways to conduct global clinical trials there.
Indian pharma major Aurobindo Pharma is reportedly in talks to buy drugmaker Zentiva based in Prague for an estimated price of as much as $5.5 billion.
.jpeg "Dr. Lal PathLabs First in India to Use AI for Cancer Diagnosis")
India is experiencing a revolution in the diagnostic industry with Dr. Lal PathLabs becoming the first lab in the country to utilize deep learning based artificial intelligence module to detect lymph node metastasis including micro-metastasis in pati
In the next years, DavaIndia, a private generic pharmacy retail chain owned by Gujarat-based Zota Healthcare, plans to grow from its existing 1,600 locations to over 3,000
Thermo Fisher Scientific announced plans to make significant investments in India’s biopharma infrastructure, with new facilities that will enhance the biopharma manufacturing capabilities. The announcements came when senior executives addressed
.jpeg "Alcon launches UNITY surgical platforms in India")
Alcon, the world leader in eye care, announced the commercial launch of its next-generation surgical platforms, the UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS) in India. The combined VCS console has been made a...
In a revolutionary stride that will change the landscape of cancer diagnostics in India, Dr. Lal PathLabs (DLPL) has become the first laboratory in the country to implement a deep learning based AI module for the identification of lymph node
Suneeta Reddy, the Managing Director of Apollo Hospitals Enterprise Ltd., has sold a 1.3% stake in the company for ?1,489 crore. The deal, handled through a block trade at ?7,850 per share with Morgan Stanley as the broker, was aimed at reducin...
Health Canada has licensed Ozempic (semaglutide injection) as the first-and-only drug to be used for once-weekly treatment of type 2 diabetes (T2D) and for the reduction of the risk of progression of kidney disease, end-stage kidney di...
A contract development and manufacturing agreement has been signed between AnGes Inc. and Boehringer Ingelheim, a biopharmaceutical business involved in both human and animal health, for the drug ingredient of AnGes' experimental treatment for
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")